Complementary Medicines Australia (CMA) has welcomed the announcement by the National Institute of Complementary Medicine (NICM) of a clinical trial for a Chinese herbal medicine, Sailuotong, which has been shown, in pilot studies, to be effective in improving the cognitive and memory impairment associated with vascular dementia.
Read the media release here